Verano Holdings (VRNO) EBIT Margin (2021 - 2026)
Verano Holdings (VRNO) posted quarterly EBIT Margin of 6.29% for Q1 2026, down 86.0% year-over-year from 44.94% in Q1 2025, and up 108.25% quarter-over-quarter from 76.27% in Q4 2025.
Verano Holdings (VRNO) EBIT Margin (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported EBIT Margin for 6 consecutive years, with 6.29% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBIT Margin fell 86.0% year-over-year to 6.29%; the TTM figure through Mar 2026 stood at 13.29% (up 1494.0% YoY), while the FY2025 annual figure was 13.04%, up 1396.0% from the prior year.
- EBIT Margin improved to 6.29% in Q1 2026 per VRNO's latest filing, from 76.27% in the prior quarter.
- Across five years, EBIT Margin topped out at 2654.68% in Q1 2024 and bottomed at 139.26% in Q4 2024.
- Historically, EBIT Margin has averaged 144.17% across 5 years, with a median of 7.15% in 2025.
- Annual changes were most pronounced in 2024 — EBIT Margin soared 263981 bps — and 2025, when it slumped 264753 bps.
- Verano Holdings' EBIT Margin stood at 91.61% in 2022, then surged by 91 bps to 8.31% in 2023, then slumped by 1576 bps to 139.26% in 2024, then jumped by 45 bps to 76.27% in 2025, then jumped by 108 bps to 6.29% in 2026.
- Business Quant data shows VRNO's EBIT Margin at 6.29% in Q1 2026, 76.27% in Q4 2025, and 4.57% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Verano Holdings | 438.82 Mn | 353.62 Mn | 99.70 Mn | 1.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.44% |
| Mar 31, 2026 | 6.29% |
| Dec 31, 2025 | -76.27% |
| Sep 30, 2025 | 4.57% |
| Jun 30, 2025 | 12.96% |
| Mar 31, 2025 | 7.15% |
| Dec 31, 2024 | -139.26% |
| Sep 30, 2024 | 7.74% |
| Jun 30, 2024 | 12.26% |
| Mar 31, 2024 | 2,654.68% |
| Dec 31, 2023 | -8.31% |
| Sep 30, 2023 | 16.78% |
| Jun 30, 2023 | 13.00% |
| Mar 31, 2023 | 14.88% |
| Dec 31, 2022 | -91.61% |
| Sep 30, 2022 | 16.29% |
| Jun 30, 2022 | -1.02% |
| Mar 31, 2022 | 0.81% |
| Dec 31, 2021 | 13.92% |
| Sep 30, 2021 | 11.15% |